Cargando…
Intersectoral Cost of Treating Pulmonary Non-Tuberculosis Mycobacterial Disease (NTM-PD) in Germany—A Change of Perspective in Disease Management
Background: In line with its increasing prevalence, pulmonary Mycobacterium avium complex (MAC) disease (MAC-PD) gives rise to substantial healthcare costs. However, there is only limited information on the costs of intersectoral reimbursement. Objectives: Inpatient and outpatient costs for diagnosi...
Autores principales: | Diel, Roland, Mertsch, Pontus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843529/ https://www.ncbi.nlm.nih.gov/pubmed/31600981 http://dx.doi.org/10.3390/ijerph16203795 |
Ejemplares similares
-
Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK
por: Lipman, Marc, et al.
Publicado: (2020) -
Challenges of diagnosing and treating non-tuberculous mycobacterial pulmonary disease [NTM-PD]: A case series
por: Chindam, Aditya, et al.
Publicado: (2021) -
British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
por: Haworth, Charles S, et al.
Publicado: (2017) -
Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009–2014
por: Ringshausen, Felix C., et al.
Publicado: (2016) -
Cost of illness of non-multidrug-resistant tuberculosis in Germany: an update
por: Diel, Roland, et al.
Publicado: (2020)